USFDA Approval Olopatadine: A Smart Move for Alembic
USFDA approval Olopatadine marks a significant milestone for Alembic Pharmaceuticals in the $20 million market.
Drug price monitoring: Proven success in Jharkhand’s targets
Drug price monitoring has seen a 97% target achievement in Jharkhand, showcasing effective strategies in pharma regulation.
Ilumya FDA approval: Is it the Best Treatment for Psoriatic Arthritis?
Ilumya FDA approval marks a significant advancement in psoriatic arthritis treatment options.
Pharmaceutical Manufacturing Expansion: Proven Growth Strategy
Pharmaceutical Manufacturing Expansion is reshaping the industry landscape with strategic acquisitions and growth opportunities.
Asaram chest pain complaint: Worst health scare for MPs
Asaram chest pain complaint raises concerns over health and treatment options for MPs amidst land acquisition issues.
Anti-cancer drugs price drop: Is it a smart move?
Anti-cancer drugs price drop in India means savings up to 70%. Discover how this impacts patients and the healthcare industry.